Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
Braz. j. infect. dis
;
11(2): 290-292, Apr. 2007. tab
Article
in English
| LILACS
| ID: lil-454731
ABSTRACT
Antiretroviral therapy has been associated with hyperlipidemia in AIDS patients. This case illustrates the classic metabolic effects associated to the HAART including protease inhibitors and/or stavudine. It was showed that the management of the HAART-associated dyslipidaemia with conventional antihyperlipidemic therapy may fail, being the switching strategy the best option.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
HIV Infections
/
HIV Protease Inhibitors
/
Anti-HIV Agents
/
Antiretroviral Therapy, Highly Active
/
Dyslipidemias
Type of study:
Risk factors
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Braz. j. infect. dis
Journal subject:
Communicable Diseases
Year:
2007
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Federal University of Mato Grosso do Sul/BR
Similar
MEDLINE
...
LILACS
LIS